composition
Each pre-filled glass syringe for subcutaneous use contains Adalimumab 40mg/0.8ml
indications
In the management of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, crohn's disease, ulcerative colitis, psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis
Therapeutic Focus
Rheumatology
